Ride2Abide,,2019-06-06 15:33:00,125.8,VKTX From Allison GatlinIBDAGatlinICPT MDGL VKTX AGN and GILD are down today after the FDA said some of the endpoints in clinical studies might not be sufficient for approval of NASH drugs for patients with compensated cirrhosis biotech stocks investing1207 PM 6 Jun 2019 Good thing VKTX hasnt started their P2b trial just adjust their Endpoints and all good
ObeCalp,,2019-06-06 15:02:00,125.09,AGN 2017 2018 CEO Saunders takes home more than 40MM as investors lost BILLIONS Congrats Brent
Turtletrading,,2019-06-06 12:18:00,125.48,AGN Allergan plc AGN 12650 was the months biggest loser descending 14 Expect a Downtrend reversal tickeroncomappnewsSearch
commonking,,2019-06-06 11:57:00,125.4,Needs an emergency facelift right about now AGN
EstimizeAlerts,,2019-06-06 11:00:00,125.855,AGN estimates distribution heres what 9 Estimize analysts are expecting AGN to report for Q2 Reporting 0725 BMOestimizecomintroagnchar
hkm_trader,,2019-06-06 09:47:00,126.811,AGN hi Saunders I heard u r frustrated with low stock price Resign you
